Results 81 to 90 of about 21,745 (193)
Histological patterns of cutaneous adverse drug reactions
Cutaneous adverse drug reactions (ADR) are skin conditions due to a drug, regardless of the way of administration. Knowledge about their frequency, clinical manifestations and histopathological patterns is essential for prevention and early diagnosis ...
Sonia Maria Neumann Cupolilo +5 more
doaj
Iododerma after Lugol use for pre-operative preparation of thyroidectomy
A 35-year-old man with hyperthyroidism reported the sudden occurrence of ulcerated and painful oral lesions, painful ulcerative-necrotic lesions on the face, trunk, upper and lower limbs and purpuric circinate lesions on the scalp, 6 days after starting ...
David Almeida +6 more
doaj
Bullous Fixed Drug Eruption Induced by Paracetamol: Report of a Pediatric Case
Drug eruptions are among the most common adverse drug reactions, affecting approximately 3% of hospitalized patients. A fixed drug eruption (FDE) is a distinct drug-induced reaction pattern that characteristically recurs at the same skin or mucosal site.
Massimiliano Nino +3 more
doaj +1 more source
Photobiomodulation Therapy for Multiple Painful Fixed Drug Eruptions: The First Case Report. [PDF]
Palma LF +5 more
europepmc +1 more source
Drug eruptions with novel targeted therapies - immune checkpoint and EGFR inhibitors. [PDF]
Pospischil I, Hoetzenecker W.
europepmc +1 more source
Fixed Drug Eruptions (FDE) in an Urban Centre in South-South Nigeria
Background Fixed drug eruptions are adverse cutaneous reactions to ingested drugs, characterized by the formation of solitary or multiple erythematous patches, plaques, bullae or erosions that reoccur at an identical skin site within hours of re ...
Altraide, Dasetima Dandeson +2 more
core
Anticonvulsant Drugs and Severe Adverse Cutaneous Drug Reactions: A Longitudinal Observational Study
Background: Severe Adverse Cutaneous Reactions to Drugs (SACRDs) are skin eruptions due to drugs, which can cause morbidity and morbidity in patients. Objectives: The aim of this study was to determine the offending drug/agents and clinical phenotypes of
Abbas Darjani +4 more
doaj
Diagnostic Tools and Biomarkers for Severe Drug Eruptions. [PDF]
Yoshioka M, Sawada Y, Nakamura M.
europepmc +1 more source
SORAFENIB INDUCED ACNEIFORM ERUPTIONS: A CASE REPORT
Sorafenib an oral tyrosine kinase inhibitor is used in the treatment of hepatocellular carcinoma, renal cell carcinoma and thyroid cancer. Sorafenib acts by inhibiting various kinases like tyrosine kinase, RET tyrosine kinase, endothelial growth factor ...
Balaji Ommurugan +2 more
core +2 more sources

